High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I-Reference-Cited by-同舟云学术

High efficacy of switching to bictegravir/emtricitabine/tenofovir alafenamide in people with suppressed HIV and preexisting M184V/I

Published:2022-04-23 Issue:11 Volume:36 Page:1511-1520
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Sax Paul E.,Andreatta Kristen,Molina Jean-Michel,Daar Eric S.,Hagins Debbie,Acosta Rima,D’Antoni Michelle L.,Chang Silvia,Martin Ross,Liu Hui,Blair Christiana,McNicholl Ian,Gallant Joel,Collins Sean E.,Martin Hal,White Kirsten L.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference53 articles.

1. Safety and efficacy of lamivudine-zidovudine combination therapy in antiretroviral-naive patients;Katlama;JAMA,1996

2. Trends in HIV-1 reverse transcriptase resistance-associated mutations and antiretroviral prescription data from 2003–2010;Miller;Antivir Ther,2012

3. Development of HIV-1 resistance to (−)2’-deoxy-3’-thiacytidine in patients with AIDS or advanced AIDS-related complex;Wainberg;AIDS,1995

4. Evolution of lamivudine resistance in human immunodeficiency virus type 1-infected individuals: the relative roles of drift and selection;Frost;J Virol,2000

5. Rapid changes in human immunodeficiency virus type 1 RNA load and appearance of drug-resistant virus populations in persons treated with lamivudine (3TC);Schuurman;J Infect Dis,1995

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acquired Human Immunodeficiency Virus Type 1 Drug Resistance in Rhode Island, USA, 2004–2021;The Journal of Infectious Diseases;2024-07-23

2. HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis B Initiating Therapy With Bictegravir/Emtricitabine/Tenofovir Alafenamide or Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate: A Subanalysis of ALLIANCE Data;JAIDS Journal of Acquired Immune Deficiency Syndromes;2024-04-23

3. Type 1 Human Immunodeficiency Virus (HIV-1) Incidence, Adherence, and Drug Resistance in Individuals Taking Daily Emtricitabine/Tenofovir Disoproxil Fumarate for HIV-1 Pre-exposure Prophylaxis: Pooled Analysis From 72 Global Studies;Clinical Infectious Diseases;2024-03-14

4. HIV epidemiology, prevention, treatment, and implementation strategies for public health;The Lancet;2024-02

5. Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis;Open Forum Infectious Diseases;2023-10-27